Evaluation of Memorial Sloan‐Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma

To evaluate the validity of Memorial Sloan‐Kettering Cancer Center (MSKCC) and International Extranodal Lymphoma Study Group (IELSG) prognostic scoring systems for Overall Survival (OS) in intracranial Primary CNS lymphoma (PCNSL) of all patients diagnosed at a single center.

[1]  R. Amini,et al.  Population-based experience on primary central nervous system lymphoma 2000–2012: the incidence is increasing , 2017, Acta oncologica.

[2]  J. Blay,et al.  First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  M. Eriksson,et al.  Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group , 2015, Haematologica.

[4]  E. Fraser,et al.  New approaches in primary central nervous system lymphoma. , 2015, Chinese clinical oncology.

[5]  E. Thiel,et al.  Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma , 2015, Neurology.

[6]  J. Blay,et al.  Evidence of time‐dependent prognostic factors predicting early death but not long‐term outcome in primary CNS lymphoma: a study of 91 patients , 2013, Hematological oncology.

[7]  M. Dreyling,et al.  Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation , 2013, Haematologica.

[8]  E. Thiel,et al.  Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  J. O'Brien,et al.  Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI , 2012, Clinical Cancer Research.

[10]  P. Wen,et al.  Survival among patients with primary central nervous system lymphoma, 1973–2004 , 2011, Journal of Neuro-Oncology.

[11]  J. Blay,et al.  Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA). , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  E. Thiel,et al.  Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort. , 2010, Neuro-oncology.

[13]  A. Espeland,et al.  AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989–2003 , 2008, BMC Cancer.

[14]  D. Nelson,et al.  Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  L. Deangelis,et al.  Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  A. Brandes,et al.  MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas , 2006, Neurology.

[17]  F. Graus,et al.  In response to Drs. Ferreri and Reni , 2005 .

[18]  M. Reni,et al.  Establishing a prognostic score for primary CNS lymphomas. , 2005, International journal of radiation oncology, biology, physics.

[19]  A. López-Guillermo,et al.  Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. , 2004, International journal of radiation oncology, biology, physics.

[20]  J. Blay,et al.  Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  L. Deangelis,et al.  Treatment for primary CNS lymphoma: the next step. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.